Bodal Chemicals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
BODALCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bodal Chemicals announced its unaudited financial results for the quarter ended June 30, 2025. Consolidated revenue from operations rose to Rs. 4,542 million from Rs. 4,220 million in Q1 FY25 (about 7.6% growth), while consolidated profit after tax swung to Rs. 95.33 million from a loss of Rs. 11.75 million a year ago. On a standalone basis, PAT jumped sharply to Rs. 103.42 million from Rs. 11.40 million, with EPS rising to Rs. 0.82. The board also approved re-appointments of Mr. Mayank K Mehta as Independent Director (5-year second term), Mr. Suresh J Patel as Chairman & MD (3-year term), and Mr. Bhavin S Patel as Executive Director (3-year term). Statutory auditor Naresh J Patel & Co. is merging with M/s B N P S and Associates LLP, prompting a change in statutory auditor. The board also approved sale of 7.86 acres of excess land at Unit-12 to a buyer who will consume the company's chlorine byproduct, supporting uninterrupted production.
A clear profit turnaround from a loss in Q1 FY25 signals strong operational recovery and should be viewed positively by shareholders. The auditor change is driven by a firm merger rather than quality concerns, and the land sale is expected to aid chlorine offtake and production continuity.